Corneal Endothelial Cell Loss
Descemet Stripping Endothelial Keratoplasty
Keratoplasty, Penetrating
Corneal Edema
Endothelial Cells
Cornea
Fuchs' Endothelial Dystrophy
Corneal Transplantation
Descemet Membrane
Cell Count
Endothelium
Phacoemulsification
Anterior Chamber
Lens Implantation, Intraocular
Cells, Cultured
Phakic Intraocular Lenses
Sodium Tetradecyl Sulfate
Tissue Donors
Cattle
Collagen Type VIII
Safety of DSAEK in patients with previous glaucoma filtering surgery. (1/26)
(+info)Risk factors for endothelial cell loss after phacoemulsification: comparison in different anterior chamber depth groups. (2/26)
(+info)Effect of incision width on graft survival and endothelial cell loss after Descemet stripping automated endothelial keratoplasty. (3/26)
(+info)Donor risk factors for graft failure in a 20-year study of penetrating keratoplasty. (4/26)
(+info)Clinicopathologic findings in failed descemet stripping automated endothelial keratoplasty. (5/26)
(+info)Anterior segment parameters using Pentacam and prediction of corneal endothelial cell loss after cataract surgery. (6/26)
(+info)Corneal endothelial toxicity of air and SF6. (7/26)
(+info)Primary cilia dynamics instruct tissue patterning and repair of corneal endothelium. (8/26)
(+info)Corneal endothelial cell loss refers to the decrease in the number of corneal endothelial cells, which is a layer of cells that line the inner surface of the cornea. These cells are essential for maintaining the clarity and health of the cornea, as they help to pump fluids out of the cornea and maintain its transparency.
Corneal endothelial cell loss can occur due to various reasons such as aging, eye trauma, surgery (such as cataract surgery), diseases (such as Fuchs' dystrophy), or inherited conditions. When the number of endothelial cells decreases below a certain threshold, it can lead to corneal swelling, cloudiness, and vision loss.
The rate of corneal endothelial cell loss varies from person to person, but on average, people lose about 0.6% of their endothelial cells per year. Factors such as age, certain medical conditions, and previous eye surgery can increase the rate of cell loss. In some cases, corneal transplantation may be necessary to replace damaged or lost endothelial cells and restore vision.
The endothelium of the cornea is the thin, innermost layer of cells that lines the inner surface of the cornea, which is the clear, dome-shaped structure at the front of the eye. This single layer of specialized cells is essential for maintaining the transparency and proper hydration of the cornea, allowing light to pass through it and focus on the retina.
The endothelial cells are hexagonal in shape and have tight junctions between them, creating a semi-permeable barrier that controls the movement of water and solutes between the corneal stroma (the middle layer of the cornea) and the anterior chamber (the space between the cornea and the iris). The endothelial cells actively pump excess fluid out of the cornea, maintaining a delicate balance of hydration that is critical for corneal clarity.
Damage to or dysfunction of the corneal endothelium can result in corneal edema (swelling), cloudiness, and loss of vision. Factors contributing to endothelial damage include aging, eye trauma, intraocular surgery, and certain diseases such as Fuchs' dystrophy and glaucoma.
Descemet Stripping Endothelial Keratoplasty (DSEK) is a type of corneal transplant surgery that involves replacing the damaged endothelium (inner layer) of the cornea with healthy endothelial cells from a donor. In this procedure, the surgeon removes the patient's Descemet's membrane (a thin, clear tissue beneath the endothelium) along with the damaged endothelium. Then, a thin disc of donor tissue, which includes both the endothelium and a small portion of the adjacent corneal stroma, is inserted into the eye and positioned using an air bubble. The new endothelial cells help to pump excess fluid out of the cornea, allowing it to become clear again. DSEK typically results in faster visual recovery and lower rejection rates compared to traditional full-thickness corneal transplantation.
Penetrating keratoplasty (PK) is a type of corneal transplant surgery where the entire thickness of the host's damaged or diseased cornea is removed and replaced with a similar full-thickness portion of a healthy donor's cornea. The procedure aims to restore visual function, alleviate pain, and improve the structural integrity of the eye. It is typically performed for conditions such as severe keratoconus, corneal scarring, or corneal ulcers that cannot be treated with other, less invasive methods. Following the surgery, patients may require extended recovery time and rigorous postoperative care to minimize the risk of complications and ensure optimal visual outcomes.
Corneal edema is a medical condition characterized by the accumulation of fluid in the cornea, which is the clear, dome-shaped surface at the front of the eye. This buildup of fluid causes the cornea to swell and thicken, resulting in blurry or distorted vision. Corneal edema can be caused by various factors, including eye injuries, certain medications, eye surgeries, and diseases that affect the eye's ability to pump fluids out of the cornea. In some cases, corneal edema may resolve on its own or with treatment, but in severe cases, it may require a corneal transplant.
Endothelial cells are the type of cells that line the inner surface of blood vessels, lymphatic vessels, and heart chambers. They play a crucial role in maintaining vascular homeostasis by controlling vasomotor tone, coagulation, platelet activation, and inflammation. Endothelial cells also regulate the transport of molecules between the blood and surrounding tissues, and contribute to the maintenance of the structural integrity of the vasculature. They are flat, elongated cells with a unique morphology that allows them to form a continuous, nonthrombogenic lining inside the vessels. Endothelial cells can be isolated from various tissues and cultured in vitro for research purposes.
The cornea is the clear, dome-shaped surface at the front of the eye. It plays a crucial role in focusing vision. The cornea protects the eye from harmful particles and microorganisms, and it also serves as a barrier against UV light. Its transparency allows light to pass through and get focused onto the retina. The cornea does not contain blood vessels, so it relies on tears and the fluid inside the eye (aqueous humor) for nutrition and oxygen. Any damage or disease that affects its clarity and shape can significantly impact vision and potentially lead to blindness if left untreated.
Fuchs' Endothelial Dystrophy is a medical condition that affects the eye's cornea. It is a slowly progressing disorder that causes the endothelium, a thin layer of cells lining the inner surface of the cornea, to deteriorate and eventually fail to function properly. This results in swelling of the cornea, leading to cloudy vision, distorted vision, and sensitivity to light.
The condition is typically inherited and tends to affect both eyes. It is more common in women than in men and usually becomes apparent after the age of 50. There is no cure for Fuchs' Endothelial Dystrophy, but treatments such as corneal transplantation can help improve vision and alleviate symptoms.
Corneal transplantation, also known as keratoplasty, is a surgical procedure in which all or part of a damaged or diseased cornea is replaced with healthy corneal tissue from a deceased donor. The cornea is the clear, dome-shaped surface at the front of the eye that plays an important role in focusing vision. When it becomes cloudy or misshapen due to injury, infection, or inherited conditions, vision can become significantly impaired.
During the procedure, the surgeon carefully removes a circular section of the damaged cornea and replaces it with a similarly sized piece of donor tissue. The new cornea is then stitched into place using very fine sutures that are typically removed several months after surgery.
Corneal transplantation has a high success rate, with more than 90% of procedures resulting in improved vision. However, as with any surgical procedure, there are risks involved, including infection, rejection of the donor tissue, and bleeding. Regular follow-up care is essential to monitor for any signs of complications and ensure proper healing.
The Descemet membrane is the thin, transparent basement membrane that is produced by the corneal endothelial cells. It is located between the corneal stroma and the corneal endothelium, which is the innermost layer of the cornea. The Descemet membrane provides structural support for the corneal endothelium and helps to maintain the proper hydration and clarity of the cornea. It is named after the French physician Jean Descemet, who first described it in 1752.
"Cell count" is a medical term that refers to the process of determining the number of cells present in a given volume or sample of fluid or tissue. This can be done through various laboratory methods, such as counting individual cells under a microscope using a specialized grid called a hemocytometer, or using automated cell counters that use light scattering and electrical impedance techniques to count and classify different types of cells.
Cell counts are used in a variety of medical contexts, including hematology (the study of blood and blood-forming tissues), microbiology (the study of microscopic organisms), and pathology (the study of diseases and their causes). For example, a complete blood count (CBC) is a routine laboratory test that includes a white blood cell (WBC) count, red blood cell (RBC) count, hemoglobin level, hematocrit value, and platelet count. Abnormal cell counts can indicate the presence of various medical conditions, such as infections, anemia, or leukemia.
The endothelium is the thin, delicate tissue that lines the interior surface of blood vessels and lymphatic vessels. It is a single layer of cells called endothelial cells that are in contact with the blood or lymph fluid. The endothelium plays an essential role in maintaining vascular homeostasis by regulating blood flow, coagulation, platelet activation, immune function, and angiogenesis (the formation of new blood vessels). It also acts as a barrier between the vessel wall and the circulating blood or lymph fluid. Dysfunction of the endothelium has been implicated in various cardiovascular diseases, diabetes, inflammation, and cancer.
Phacoemulsification is a surgical procedure used in cataract removal. It involves using an ultrasonic device to emulsify (break up) the cloudy lens (cataract) into small pieces, which are then aspirated or sucked out through a small incision. This procedure allows for smaller incisions and faster recovery times compared to traditional cataract surgery methods. After the cataract is removed, an artificial intraocular lens (IOL) is typically implanted to replace the natural lens and restore vision.
Corneal diseases are a group of disorders that affect the cornea, which is the clear, dome-shaped surface at the front of the eye. The cornea plays an important role in focusing vision, and any damage or disease can cause significant visual impairment or loss. Some common types of corneal diseases include:
1. Keratoconus: A progressive disorder in which the cornea thins and bulges outward into a cone shape, causing distorted vision.
2. Fuchs' dystrophy: A genetic disorder that affects the inner layer of the cornea called the endothelium, leading to swelling, cloudiness, and decreased vision.
3. Dry eye syndrome: A condition in which the eyes do not produce enough tears or the tears evaporate too quickly, causing discomfort, redness, and blurred vision.
4. Corneal ulcers: Open sores on the cornea that can be caused by infection, trauma, or other factors.
5. Herpes simplex keratitis: A viral infection of the cornea that can cause recurrent episodes of inflammation, scarring, and vision loss.
6. Corneal dystrophies: Inherited disorders that affect the structure and clarity of the cornea, leading to visual impairment or blindness.
7. Bullous keratopathy: A condition in which the endothelium fails to pump fluid out of the cornea, causing it to swell and form blisters.
8. Corneal trauma: Injury to the cornea caused by foreign objects, chemicals, or other factors that can lead to scarring, infection, and vision loss.
Treatment for corneal diseases varies depending on the specific condition and severity of the disease. Options may include eyedrops, medications, laser surgery, corneal transplantation, or other treatments.
The anterior chamber is the front portion of the eye, located between the cornea (the clear front "window" of the eye) and the iris (the colored part of the eye). It is filled with a clear fluid called aqueous humor that provides nutrients to the structures inside the eye and helps maintain its shape. The anterior chamber plays an important role in maintaining the overall health and function of the eye.
Intraocular lens (IOL) implantation is a surgical procedure that involves placing a small artificial lens inside the eye to replace the natural lens that has been removed. This procedure is typically performed during cataract surgery, where the cloudy natural lens is removed and replaced with an IOL to restore clear vision.
During the procedure, a small incision is made in the eye, and the cloudy lens is broken up and removed using ultrasound waves or laser energy. Then, the folded IOL is inserted through the same incision and positioned in the correct place inside the eye. Once in place, the IOL unfolds and is secured into position.
There are several types of IOLs available, including monofocal, multifocal, toric, and accommodating lenses. Monofocal lenses provide clear vision at one distance, while multifocal lenses offer clear vision at multiple distances. Toric lenses correct astigmatism, and accommodating lenses can change shape to focus on objects at different distances.
Overall, intraocular lens implantation is a safe and effective procedure that can help restore clear vision in patients with cataracts or other eye conditions that require the removal of the natural lens.
Cataract extraction is a surgical procedure that involves removing the cloudy lens (cataract) from the eye. This procedure is typically performed to restore vision impairment caused by cataracts and improve overall quality of life. There are two primary methods for cataract extraction:
1. Phacoemulsification: This is the most common method used today. It involves making a small incision in the front part of the eye (cornea), inserting an ultrasonic probe to break up the cloudy lens into tiny pieces, and then removing those pieces with suction. After removing the cataract, an artificial intraocular lens (IOL) is inserted to replace the natural lens and help focus light onto the retina.
2. Extracapsular Cataract Extraction: In this method, a larger incision is made on the side of the cornea, allowing the surgeon to remove the cloudy lens in one piece without breaking it up. The back part of the lens capsule is left intact to support the IOL. This technique is less common and typically reserved for more advanced cataracts or when phacoemulsification cannot be performed.
Recovery from cataract extraction usually involves using eye drops to prevent infection and inflammation, as well as protecting the eye with a shield or glasses during sleep for a few weeks after surgery. Most people experience improved vision within a few days to a week following the procedure.
"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.
Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.
It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.
Phakic Intraocular Lenses (PIOLs) are a type of surgical implant used in refractive eye surgery to correct vision problems such as myopia (nearsightedness), hyperopia (farsightedness), and astigmatism. These lenses are placed inside the eye, specifically between the cornea and the natural lens (crystalline lens) of the eye, without removing the natural lens. This is why they are called "phakic," which means the natural lens remains in place.
PIOLs can provide an alternative to other refractive surgeries like LASIK or PRK, particularly for individuals with high levels of refractive error who may not be suitable candidates for those procedures. The procedure to implant a phakic intraocular lens is typically performed on an outpatient basis and takes only a few minutes.
There are two main types of PIOLs: anterior chamber phakic lenses, which are placed in front of the iris, and posterior chamber phakic lenses, which are placed behind the iris but in front of the natural lens. Both types of lenses have their own advantages and disadvantages, and the choice between them depends on various factors such as the patient's eye anatomy and the specific type and degree of refractive error.
It is important to note that, like any surgical procedure, there are potential risks associated with PIOL implantation, including infection, increased intraocular pressure, cataract formation, and changes in vision. Therefore, a thorough evaluation by an eye care professional is necessary before deciding if this type of surgery is appropriate for an individual patient.
Sodium tetradecyl sulfate (STS) is a sclerosing agent that is used in the treatment of small varicose veins and spider veins. It works by irritating the lining of the blood vessel, causing it to swell and stick together, which ultimately leads to the closure of the affected vein.
When STS is injected into the vein, it causes local inflammation, which triggers the body's natural healing process. Over time, the treated vein turns into scar tissue and gets absorbed by the body. This procedure is typically performed in a doctor's office and may require multiple sessions for optimal results.
It is important to note that STS should only be administered by trained medical professionals, as improper use can lead to serious complications such as deep vein thrombosis or pulmonary embolism.
A tissue donor is an individual who has agreed to allow organs and tissues to be removed from their body after death for the purpose of transplantation to restore the health or save the life of another person. The tissues that can be donated include corneas, heart valves, skin, bone, tendons, ligaments, veins, and cartilage. These tissues can enhance the quality of life for many recipients and are often used in reconstructive surgeries. It is important to note that tissue donation does not interfere with an open casket funeral or other cultural or religious practices related to death and grieving.
"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.
Collagen type VIII is a less common type of collagen that is found in the eyes, specifically in the basement membrane of the cornea and the blood vessels of the eye. It is a network-forming collagen and is believed to play a role in maintaining the structural integrity and stability of these tissues. Mutations in the genes encoding for collagen type VIII have been associated with certain eye disorders, such as Fuchs' endothelial corneal dystrophy.
Here is a medical definition from the US National Library of Medicine:
"Collagen, type VIII, alpha-1 (COL8A1) is a gene that provides instructions for making one component of a type VIII collagen protein called collagen VIII alpha-1 chain. Collagen proteins are important building blocks for many tissues in the body, including tendons, ligaments, and the cornea, which is the clear outer covering of the eye.
Collagen VIII is found in the basement membrane, a thin layer of protein that surrounds many types of cells and helps to anchor them to surrounding tissue. In the eye, collagen VIII is produced by cells called endothelial cells, which line the inside surface of the cornea. Collagen VIII forms networks with other proteins that help maintain the structural integrity and stability of the cornea.
Mutations in the COL8A1 gene can cause Fuchs' endothelial corneal dystrophy, a progressive eye disorder characterized by the gradual clouding of the cornea." ()
Intraocular lenses (IOLs) are artificial lens implants that are placed inside the eye during ophthalmic surgery, such as cataract removal. These lenses are designed to replace the natural lens of the eye that has become clouded or damaged, thereby restoring vision impairment caused by cataracts or other conditions.
There are several types of intraocular lenses available, including monofocal, multifocal, toric, and accommodative lenses. Monofocal IOLs provide clear vision at a single fixed distance, while multifocal IOLs offer clear vision at multiple distances. Toric IOLs are designed to correct astigmatism, and accommodative IOLs can change shape and position within the eye to allow for a range of vision.
The selection of the appropriate type of intraocular lens depends on various factors, including the patient's individual visual needs, lifestyle, and ocular health. The implantation procedure is typically performed on an outpatient basis and involves minimal discomfort or recovery time. Overall, intraocular lenses have become a safe and effective treatment option for patients with vision impairment due to cataracts or other eye conditions.